Bafna Pharmaceuticals Statistics

Total Valuation

NSE:BAFNAPH has a market cap or net worth of INR 2.53 billion. The enterprise value is 2.85 billion.

Market Cap	2.53B
Enterprise Value	2.85B

Important Dates

The last earnings date was Wednesday, February 11, 2026.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	n/a

Share Statistics

NSE:BAFNAPH has 23.66 million shares outstanding. The number of shares has decreased by -0.14% in one year.

Current Share Class	23.66M
Shares Outstanding	23.66M
Shares Change (YoY)	-0.14%
Shares Change (QoQ)	-0.52%
Owned by Insiders (%)	4.97%
Owned by Institutions (%)	4.36%
Float	3.34M

Valuation Ratios

The trailing PE ratio is 26.18.

PE Ratio	26.18
Forward PE	n/a
PS Ratio	1.72
PB Ratio	2.77
P/TBV Ratio	2.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	29.52
EV / Sales	1.93
EV / EBITDA	17.60
EV / EBIT	25.03
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.36
Debt / EBITDA	2.00
Debt / FCF	n/a
Interest Coverage	3.47

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	9.24%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	4.70%
Revenue Per Employee	3.63M
Profits Per Employee	237,963
Employee Count	406
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +30.23% in the last 52 weeks. The beta is 0.00, so NSE:BAFNAPH's price volatility has been lower than the market average.

Beta (5Y)	0.00
52-Week Price Change	+30.23%
50-Day Moving Average	123.99
200-Day Moving Average	120.27
Relative Strength Index (RSI)	37.64
Average Volume (20 Days)	4,228

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:BAFNAPH had revenue of INR 1.47 billion and earned 96.61 million in profits. Earnings per share was 4.09.

Revenue	1.47B
Gross Profit	477.31M
Operating Income	113.98M
Pretax Income	96.61M
Net Income	96.61M
EBITDA	162.09M
EBIT	113.98M
Earnings Per Share (EPS)	4.09

Full Income Statement

Balance Sheet

The company has 2.54 million in cash and 324.03 million in debt, giving a net cash position of -321.48 million or -13.59 per share.

Cash & Cash Equivalents	2.54M
Total Debt	324.03M
Net Cash	-321.48M
Net Cash Per Share	-13.59
Equity (Book Value)	912.28M
Book Value Per Share	38.54
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 32.37%, with operating and profit margins of 7.73% and 6.55%.

Gross Margin	32.37%
Operating Margin	7.73%
Pretax Margin	6.55%
Profit Margin	6.55%
EBITDA Margin	10.99%
EBIT Margin	7.73%
FCF Margin	n/a

Dividends & Yields

NSE:BAFNAPH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.14%
Shareholder Yield	0.14%
Earnings Yield	3.82%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2